1. At a Glance – The Vitamin D Drama You Didn’t Ask For
If there was ever a company that could sell you sunshine in a capsule and then quietly flip a real estate deal on the side like a Mumbai broker uncle — it’s Fermenta Biotech. One minute they’re saving the world from Vitamin D deficiency, the next minute they’re booking profits from selling buildings like it’s OLX premium listing. And just when you think “Boss, growth aa gaya!”, quarterly numbers arrive and slap you with a -68% PAT decline.
But wait — zoom out, and suddenly the picture changes. 9MFY26 revenue is ₹413.6 crore with PAT ₹51.7 crore, up ~20% YoY.
So what is this company really?
A pharma play? A nutraceutical growth story? A real estate opportunist?
Or a classic Indian hybrid business that does everything except make things simple?
And the real question:
Is Fermenta finally stabilising after its Vitamin D hangover… or is this just another temporary “recovery rally” story?
2. Introduction – From Pandemic Hero to Reality Check
During COVID, Vitamin D became the new “haldi doodh”. Everyone suddenly needed immunity boosters. Fermenta — being a major Vitamin D3 manufacturer — basically got a free marketing campaign sponsored by global panic.
Then what happened?
Demand crashed. Inventory piled up. Prices dropped. Margins said goodbye.
CARE Ratings literally confirmed this rollercoaster — weak FY23–FY24 due to excess inventory and falling realisations, followed by a recovery in FY25.
Now in FY26, the company is trying to convince investors:
“Relax guys, this time it’s real growth.”
And honestly, there are signs:
- 9M revenue up 25% YoY
- EBITDA up 20%
- PAT up 20%
But quarterly reality:
- PAT down 68% YoY
- EBITDA down 49% YoY
Why?
Because last year had juicy real estate income.
So here’s the setup:
- Core business improving
- But headline numbers distorted
Classic Indian financial storytelling.
Now tell me honestly —
Do you prefer a clean boring company or a confusing multi-income jugaad machine like this?
3. Business Model – WTF Do They Even Do?
Let’s decode this without corporate jargon.
Core Business: Vitamin D Mafia
Fermenta is basically:
- One of India’s major Vitamin D3 manufacturers
- Supplies pharma, food, supplements, animal feed
And importantly:
👉 Non-China dependent supply chain
👉 Backward integrated cholesterol production
That’s like saying:
“I don’t depend on China AND I make my own raw material.”
Respect.
Segment Breakdown
1. Nutrition (Main Game)
- Vitamin D3 (human + animal)
- Premixes, fortified food
- Nutraceutical ingredients
This is where real growth is happening.
2. APIs & Enzymes
- Pharma intermediates
- Green chemistry
- Industrial enzymes
Basically side hustle, but with potential.
3. Real Estate (Plot Twist)
- IT parks in Thane
- Land monetisation
- Sale of properties
This is the “hidden joker card” in earnings.
Global Presence
- 60+ countries
- 350+ clients
- Europe + US heavy exposure
The Real Truth
Fermenta is
